Replies to post #2093 on GTC Biotherapeutics (fka GTCB)

[Lewis R Goudy]

The aerosol ALI patent application cites Murakami et al. (n=16)
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&l...
but the application itself references n=24:
http://v3.espacenet.com/textdes?DB=EPODOC&IDX=EP1713500&F=0&QPN=EP1713500
so maybe these are disjoint studies at UTMB.
The instilled pathogen's name is apparently omitted from the
Murakami abstract--I suppose it the same (P. aeruginosa) as
specified in the application.

It may be a blind alley but the prospect of provisioning a lot
of field kits recurrently is attractive. Also a military need
might cut some regulatory red tape just as with Fvii.